Loading
Journal of Cellular Immunology
ISSN: 2689-2812
Can Molecular Biomarkers be Utilized to Determine Appropriate Adjuvant Therapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC)?
Early-stage NSCLC, encompassing resectable stage I-III are curable, and represents 25% of all lung cancers. The management of non-metastatic NSCLC is a rapidly changing area of clinical oncology, where utilization of molecular biomarkers has become a cornerstone in informing appropriate management. In current clinical practice, adjuvant chemotherapy is recommended after surgical resection for tumors ≥ 4 cms in size (AJCC 7th stage IB, AJCC 8th stage IIA, and higher stage groups thereafter).
J Cell Immunol, 2024, Volume 6, Issue 2, p82-86 | DOI: 10.33696/immunology.6.193The Natural History of Post-Chikungunya Viral Arthritis Disease Activity and T-cell Immunology: A Cohort Study
Background: Chikungunya virus (CHIKV) is an alphavirus spread by mosquitos that causes arthralgias and arthritis that may last for years. The objective of this study was to describe the arthritis progression and T cell immunology over a two-year period. Methods: A cohort of 40 cases of serologically confirmed CHIKV from Magdalena and Atlántico, Colombia were followed in 2019 and again in 2021. Arthritis disease severity, disability, pain, stiffness, physical function, mobility, fatigue, anxiety, sleep disturbances and depression were assessed.
J Cell Immunol, 2024, Volume 6, Issue 2, p64-75 | DOI: 10.33696/immunology.6.191Essentials of CAR-T Therapy and Associated Microbial Challenges in Long Run Immunotherapy
Chimeric antigen receptor (CAR)-T cell therapy has shown potential in improving outcomes for individuals with hematological malignancies. However, achieving long-term full remission for blood cancer remains challenging due to severe life-threatening toxicities such as limited anti-tumor efficacy, antigen escape, trafficking restrictions, and limited tumor invasion. Furthermore, the interactions between CAR-T cells and their host tumor microenvironments have a significant impact on CAR-T function.
J Cell Immunol, 2024, Volume 6, Issue 1, p25-50 | DOI: 10.33696/immunology.6.189Preliminary Evidence of Differentially Induced Immune Responses by Microparticle-adsorbed LPS in Patients with Crohn’s Disease
Inorganic microparticles are ubiquitous in the modern Western diet present as food additives and are actively scavenged by microfold (M) cells overlying human intestinal lymphoid aggregates. In Crohn’s disease (CD), inflammation is caused by the inability of the intestinal mucosa to sustain tolerance to gut luminal factors including bacteria and their by-products.
J Cell Immunol, 2022, Volume 4, Issue 6, p211-218 | DOI: 10.33696/immunology.4.152Going above and Beyond: Using an Attenuated Herpes Viral Vaccine Vector to Elicit Protective Immune Responses Through Neutralizing and Non-neutralizing Functions of Antibodies
The COVID-19 pandemic has made the development of novel vaccines a high priority for public health. While many vaccines have focused on the generation of neutralizing antibodies, we have discovered a novel herpes simplex virus (HSV) vaccine candidate, designated ΔgD-2, that can preferentially elicit non-neutralizing antibodies that function through Fcγ receptor (FcγR) activation
J Cell Immunol, 2022, Volume 4, Issue 5, p185-193 | DOI: 10.33696/immunology.4.149The Issue of Monocyte Activation in ASD: Troubles with Translation
Autism spectrum disorder (ASD) prevalence has increased year on year for the past two decades and currently affects 1 in 44 individuals in the US. An increasing number of studies have pointed to increased immune activation as both an etiological agent and also involved in the ongoing pathological process of ASD. Both adaptive and innate immune responses have been implicated. Evidence of innate dysregulation has so far included increased production of innate inflammatory cytokines, increased cell numbers, and altered activation in monocytes in the blood and microglia in the brain.
J Cell Immunol, 2022, Volume 4, Issue 5, p167-170 | DOI: 10.33696/immunology.4.146Inulin Supplementation Mitigates Gut Dysbiosis and Brain Impairment Induced by Mild Traumatic Brain Injury during Chronic Phase
Approximately 1.6-3.8 million people sustain a mild traumatic brain injury (mTBI) in the US annually. This amounts to the hospitalization of 100-300 per 100,000 young adults. The Centers for Disease Control and Prevention reports that around 5.3 million people live with a permanent disability after mTBI, and there are currently no known restorative therapies.
J Cell Immunol, 2022, Volume 4, Issue 2, p50-64 | DOI: 10.33696/immunology.4.132Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer’s Disease than Amyloid or Tau
Alzheimer’s disease (AD) research has long been dominated with communications regarding the amyloid hypothesis and targeting amyloid clearance through pharmacological therapies from the brain [1].
J Cell Immunol, 2022, Volume 4, Issue 1, p15-18 | DOI: 10.33696/immunology.4.128Exploring and Targeting the Tumor Immune Microenvironment of Neuroblastoma
Neuroblastoma is derived from the developing sympathetic nervous system and is the most common extracranial solid tumor of childhood.
J Cell Immunol, 2021, Volume 3, Issue 5, p305-316 | DOI: 10.33696/immunology.3.111The Importance of miRNA Identification During Respiratory Viral Infections
MicroRNA (miRNAs) constitute a large family of highly conserved ~21-nucleotide-long small noncoding RNAs. In mammals it is calculated to control ~50% of proteincoding genes by regulation at the post-transcriptional level affecting mRNA degradation.
J Cell Immunol, 2021, Volume 3, Issue 4, p207-214 | DOI: 10.33696/immunology.3.101Ca2 /calmodulin-dependent Protein Kinases in Leukemia Development
Calcium (Ca2+) is an intracellular universal second messenger that regulates a variety of cellular processes. Many biological processes, including gene transcription, cell cycle, migration, and apoptosis, are affected by changes in intracellular Ca2+ signaling. Disruption of normal Ca2+ signaling can cause tumorigenic phenotypes.
J Cell Immunol, 2021, Volume 3, Issue 3, p144-150 | DOI: 10.33696/immunology.3.091Structural Consequences of Variation in SARS-CoV-2 B.1.1.7
New globally circulating SARS-CoV-2 strains are causing concern about evolution of virus transmissibility, fitness and immune evasion mechanisms. A variant emerging from the United Kingdom called SARS-CoV-2 VUI 202012/01, or B.1.1.7, is thought to exhibit increased transmissibility that results from replication 4-10 times faster than the original Wuhan virus (Wuhan-Hu-1).
J Cell Immunol, 2021, Volume 3, Issue 2, p103-108 | DOI: 10.33696/immunology.3.085M1 Macrophages are More Susceptible to Necroptosis
Macrophages are important cells of the innate immune system and play a crucial role in host immune defense against infection and injury [1-3]. Macrophages form the first line of defense against airborne particles and microbes through multiple functions including phagocytosis, production of cytokines and chemokines, and antigen presentation.
J Cell Immunol, 2021, Volume 3, Issue 2, p97-102 | DOI: 10.33696/immunology.3.084Potentials of Interferons and Hydroxychloroquine for the Prophylaxis and Early Treatment of COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) causes a mild respiratory infection in most individuals. However, a portion of patients develop a severe infection resulting in the need for mechanical ventilation and ultimately death. Currently, the median infection fatality rate of coronavirus disease 2019 (COVID-19) is estimated to be 0.27% .
J Cell Immunol, 2020, Volume 2, Issue 6, p333-340 | DOI: 10.33696/immunology.2.063Hypomagnesemia and Outcomes in Hematologic Malignancies
Magnesium is an essential mineral and cofactor for hundreds of enzymes and reactions. Magnesium is essential for the regulation of cell growth, division, and differentiation as well as protein synthesis, cell signaling and structural functions.
J Cell Immunol, 2020, Volume 2, Issue 5, p245-249 | DOI: 10.33696/immunology.2.050Naltrexone as a Novel Therapeutic for Diabetic Corneal Complications
Diabetes is approaching epidemic proportions worldwide. In the United States, there are more than 30 million individuals having a confirmed diagnosis of diabetes [1,2]. Worldwide, the number of people with diabetes exceeds 400 million [3], and is expected to reach 550 million by 2030. Diabetes is associated with complications that affect nearly all systems, including vision.
J Cell Immunol, 2020, Volume 2, Issue 2, p42-46 | DOI: 10.33696/immunology.1.018Targeting the PI3K/AKT/mTOR/NFkB Axis in Ovarian Cancer
Phosphoinositol 3 kinase (PI3K) defines a class of lipid kinases that have the ability to phosphorylate the inositol ring 3?-OH group in inositol phospholipids and therefore produce phosphatidylinositol (3,4,5)-trisphosphate (PIP3) [1]. PI3K encompasses a family of enzymes divided into: Class IA PI3K which includes three isomers (?, ?, ?) and Class IB which include the group (?).
J Cell Immunol, 2020, Volume 2, Issue 2, p68-73 | DOI: 10.33696/immunology.1.022TNFAIP8: Inflammation, Immunity and Human Diseases
Inflammation can be caused by various environmental factors, including microbial infection and toxic chemical exposure. In response to inflammation, immune cells like macrophages, B and T lymphocytes, fibroblasts, endothelial cells, and various stromal cells secrete soluble polypeptide cytokine Tumor Necrosis Factor Alpha (TNF?)
J Cell Immunol, 2019, Volume 1, Issue 2, p29-34 | DOI: 10.33696/immunology.1.007Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.